Affiliation:
1. Department of Maternal and Child Health , Jordan University Of Science And Technology , Irbid 22110 , Jordan
Abstract
Abstract
Objectives
The objective of this study was to survey pregnant and lactating toward COVID-19 vaccination in Jordan and determine the predictors of this attitude
Methods
This study used a 10 min anonymous, online, cross-sectional survey to collect data. The survey was carried out between September and October 2021. Eligible study participants included all pregnant and lactating women in Jordan. The participants were recruited through social media, midwives, and gynecologists. Survey was used to collect data from the participants.
Results
The mean attitude of pregnant and lactating women toward COVID vaccination was moderate 71 (SD=100.5). Many factors were predicted the attitude of pregnant and lactating women toward COVID-19 vaccination. The factors were source of data regarding COVID-19 (B=−0.140, p=0.009), level of income (B=−0.141, p=0.009), and social status (B=0.130, p=0.034). These results mean lower income, people who frequently hearing news from news channel or ministry of health and married are showed more positive attitude toward COVID-19 vaccination for children.
Conclusions
This is a large national study regarding attitude of pregnant and lactating women toward COVID-19 vaccination in Jordan. This study found that more than 50% for the parents were hesitant to allow their children to receive COVID-19 vaccination. There were no differences between pregnant and lactating women toward COVID-19 vaccination.
Subject
Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health
Reference29 articles.
1. Skjefte, M, Ngirbabul, M, Akeju, O, Escudero, D, Hernandez-Diaz, S, Wyszynski, DF, et al.. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol 2021;36:197–211. https://doi.org/10.1007/s10654-021-00728.
2. Mortazavi, F, Mehrabadi, M, KiaeeTabar, R. Pregnant women’s well-being and worry during the COVID-19 pandemic: a cross-sectional study. BMC Pregnancy Childbirth 2021;21:1–11. https://doi.org/10.1186/s12884-021-03548-4.
3. Pfizer, B. Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study. 2021. | Pfpfizeruscom [online]. Available from: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against [Accessed 8 Jun 2021].
4. Moderna, I. Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with US FDA for emergency use authorization. Moderna. 2020. Available from: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-primary-efficacy-analysis-phase-3-cove-study [Accessed 8 Jun 2021].
5. Pratama, NR, Wafa, IA, Budi, DS, Putra, M, Wardhana, MP, Wungu, CDK. Covid-19 vaccination in pregnancy: a systematic review. medRxiv 2021;8. https://doi.org/10.1101/2021.07.04.21259985.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献